Inaktiver Wert

Ambrx Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Ambrx : Innovative Antibody Drug Conjugate (ADC) US IND Active	17.08.16
Ambrx : closes $45M round of financing	04.08.16
Ambrx : Announces New Chief Medical Officer	16.11.15
Ambrx : Names Dr. Tiecheng Qiao as CEO, Dr. Feng Tian as CSO	19.06.15
Ambrx : Chinese Consortium Enters into Agreement to Acquire Ambrx	19.06.15

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+14.84%	121 Mrd.
REGENERON PHARMACEUTICALS, INC.	+18.31%	112 Mrd.
ARGENX SE	+4.40%	22.57 Mrd.
BIONTECH SE	-18.26%	20.82 Mrd.
BEIGENE, LTD.	-14.23%	16.3 Mrd.
GENMAB A/S	-17.12%	16.19 Mrd.
WUXI APPTEC CO., LTD.	-42.36%	16.17 Mrd.
NEUROCRINE BIOSCIENCES, INC.	-0.68%	13.17 Mrd.
SAREPTA THERAPEUTICS, INC.	+21.87%	11.11 Mrd.